Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
10.35
-0.26 (-2.45%)
Jun 3, 2026, 11:29 AM CST
Shanghai No.1 Pharmacy Revenue
Shanghai No.1 Pharmacy had revenue of 484.56M CNY in the quarter ending March 31, 2026, a decrease of -3.85%. This brings the company's revenue in the last twelve months to 2.11B, up 7.86% year-over-year. In the year 2025, Shanghai No.1 Pharmacy had annual revenue of 2.13B with 11.23% growth.
Revenue (ttm)
2.11B
Revenue Growth
+7.86%
P/S Ratio
1.12
Revenue / Employee
2.58M
Employees
818
Market Cap
2.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.13B | 215.08M | 11.23% |
| Dec 31, 2024 | 1.92B | 95.64M | 5.26% |
| Dec 31, 2023 | 1.82B | -836.39M | -31.49% |
| Dec 31, 2022 | 2.66B | 1.26B | 89.94% |
| Dec 31, 2021 | 1.40B | -188.62M | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 27.52B |
| Yifeng Pharmacy Chain | 24.51B |
| LBX Pharmacy Chain Joint Stock Company | 22.28B |
| Luyan Pharma | 21.42B |
| Cachet Pharmaceutical | 18.82B |
| Yixintang Pharmaceutical Group | 17.00B |
| ShuYu Civilian Pharmacy Corp. | 10.55B |
| Jianzhijia Pharmaceutical Chain Group | 8.72B |